Metraipolis › archive › dc_ccef1df4f24d

Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptor — Europe PMC PMID:41695591

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41695591
DOI
10.1039/d5md01081k
License (as archived)
solo-consultazione
Archived
2026-11-06T11:05:41.703Z
SHA-256 of the archived text
1bb246fd0646ed04c67dbe30463b08583fe8489972408c028c14804c1760ea07
Stable URL of this page
https://metraipolis.com/documento/dc_ccef1df4f24d

How to cite

Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptor — Europe PMC PMID:41695591 — Europe PMC (en), https://europepmc.org/article/MED/41695591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccef1df4f24d (Metraipolis archive dc_ccef1df4f24d, sha256 1bb246fd0646ed04c67dbe30463b08583fe8489972408c028c14804c1760ea07)
BibTeX
@misc{dcccef1df4f24d,
  title = {Leveraging fragment-based drug discovery to advance 3D scaffolds into potent ligands: application to the histamine H1 receptor — Europe PMC PMID:41695591},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41695591},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccef1df4f24d; sha256 1bb246fd0646ed04c67dbe30463b08583fe8489972408c028c14804c1760ea07},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41695591. Agents can read the archived copy with the MCP tool read_document.